4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-21-046031
Chief Financial Officer acquired 26,187 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt Chief Financial Officer | 2021-07-06 | Conversion | +26,187 | 26,187 | D | ||
| Derivatives | |||||||
| Zuga Matt Chief Financial Officer | 2021-07-06 | Conversion · Series A-1 Preferred Stock | −15,659 | 15,659 | D | ||
| Zuga Matt Chief Financial Officer | 2021-07-06 | Conversion · Series B Preferred Stock | −10,528 | 10,528 | D | ||
Loading xslF345X03/doc4.xml…